These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16024091)

  • 1. Substance P in serum and cerebrospinal fluid of depressed patients: no effect of antidepressant treatment.
    Deuschle M; Sander P; Herpfer I; Fiebich BL; Heuser I; Lieb K
    Psychiatry Res; 2005 Jul; 136(1):1-6. PubMed ID: 16024091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
    Hellweg R; Ziegenhorn A; Heuser I; Deuschle M
    Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I; Bissette G; Dettling M; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Nemeroff CB; Holsboer F
    Depress Anxiety; 1998; 8(2):71-9. PubMed ID: 9784981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy.
    Carpenter LL; Bayat L; Moreno F; Kling MA; Price LH; Tyrka AR; Kinkead B; Owens MJ; Nemeroff CB
    Psychiatry Res; 2008 Jan; 157(1-3):123-9. PubMed ID: 17976740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine.
    Bonne O; Gill JM; Luckenbaugh DA; Collins C; Owens MJ; Alesci S; Neumeister A; Yuan P; Kinkead B; Manji HK; Charney DS; Vythilingam M
    J Clin Psychiatry; 2011 Aug; 72(8):1124-8. PubMed ID: 21208596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with paroxetine, but not amitriptyline, lowers levels of lipoprotein(a) in patients with major depression.
    Paslakis G; Kopf D; Westphal S; Gilles M; Lederbogen F; Hamann B; Heuser I; Deuschle M
    J Psychopharmacol; 2011 Oct; 25(10):1344-6. PubMed ID: 20952454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment.
    Weber-Hamann B; Kratzsch J; Kopf D; Lederbogen F; Gilles M; Heuser I; Deuschle M
    J Psychiatr Res; 2007; 41(3-4):344-50. PubMed ID: 16497334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment.
    Olsson A; Regnéll G; Träskman-Bendz L; Ekman R; Westrin A
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):479-85. PubMed ID: 15589387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
    Rao ML; Deister A; Laux G; Staberock U; Höflich G; Möller HJ
    Pharmacopsychiatry; 1996 May; 29(3):97-102. PubMed ID: 8738313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha1-acid glycoprotein in late-life depression: relationship to medical burden and genetics.
    Adeoye OM; Ferrell RE; Kirshner MA; Mulsant BH; Seligman K; Begley AE; Reynolds CF; Pollock BG
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):235-9. PubMed ID: 14653433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment.
    Weber-Hamann B; Blum WF; Kratzsch J; Gilles M; Heuser I; Deuschle M
    Pharmacopsychiatry; 2009 Jan; 42(1):23-8. PubMed ID: 19153943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels.
    Franke L; Schewe HJ; Uebelhack R; Müller-Oerlinghausen B
    Pharmacopsychiatry; 2003 Jul; 36(4):134-42. PubMed ID: 12905099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
    Huang TL; Lee CT; Liu YL
    J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
    Howland RH; Wilson MG; Kornstein SG; Clayton AH; Trivedi MH; Wohlreich MM; Fava M
    Ann Clin Psychiatry; 2008; 20(4):209-18. PubMed ID: 19034753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunction: a danish multicentre trial in general practice.
    Rosenberg C; Lauritzen L; Brix J; Jørgensen JB; Kofod P; Bayer LB
    Psychopharmacol Bull; 2007; 40(1):63-73. PubMed ID: 17285097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P serum levels are increased in major depression: preliminary results.
    Bondy B; Baghai TC; Minov C; Schüle C; Schwarz MJ; Zwanzger P; Rupprecht R; Möller HJ
    Biol Psychiatry; 2003 Mar; 53(6):538-42. PubMed ID: 12644359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.
    Van HL; Dekker J; Peen J; van Aalst G; Schoevers RA
    Psychother Psychosom; 2008; 77(6):358-64. PubMed ID: 18701832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression.
    Patankar TF; Baldwin R; Mitra D; Jeffries S; Sutcliffe C; Burns A; Jackson A
    J Affect Disord; 2007 Jan; 97(1-3):265-70. PubMed ID: 16919335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.